phne no

LORD JESUS CHRIST SAYS

- Jesus answered, "The scripture says 'Man shall not live by bread alone, but by every word that proceeds from the mouth of God'."

26 Mar 2020

Pray for people who are infected with COVID-19 or facing quarantine.

             MY PRAYER TO JESUS-

Jesus, during Your ministry on Earth You showed Your power and caring by healing people of all ages and stations of life from physical, mental, and spiritual ailments. Be present now to people who need Your loving touch because of COVID-19. May they feel Your power of healing through the care of doctors and nurses.
Take away the fear, anxiety, and feelings of isolation from people receiving treatment or under quarantine. Give them a sense of purpose in pursuing health and protecting others from exposure to the disease. Protect their families and friends and bring peace to all who love them. 
Do not be anxious about anything, but in every situation, by prayer and petition, with thanksgiving, present your requests to God.

23 Feb 2020

STOCK MARKET-ONE SMALL CAP COMPANY SHARE FOR INVESTMENT-READ ANALYSTS REPORT-


IOL Chemicals & Pharmaceuticals Ltd
Dated 3 June 19 and Vol.XXVIII No.31

(BSE Code: 524164) (CMP: Rs.213.90) (FV: Rs.10)
We first recommended this stock at Rs.63.8 on 30 October 2017. At that time, the broader markets were in a bear grip and most stocks were available 50-70% below their January 2018 high. IOL Chemicals & Pharmaceuticals has delivered 265% returns in 19 months! We recommend this stock once again based on its excellent Q4FY19 results.

Company Background: Established in 1986, IOL Chemicals & Pharmaceuticals Ltd (IOLCP) is a leading generic pharmaceutical company and a significant player in the Organic Chemicals space. It operates through two segments: Chemicals and Pharmaceuticals.

Chemicals: IOLCP is a major manufacturer in the speciality organic chemical space. It is one of the largest producers of Ethyl Acetate (87,000 TPA) and ISO Butyl Benzene (IBB) in India with over 30% of the global market share and a major player in Ibuprofen. It has forward-integrated this vertical to the pharmaceutical segment with end products such as Ethyl Acetate, IBB, MCA and Acetyl Chloride used as key raw materials for Ibuprofen. It plans to explore its presence in other industries such as paints, flexible packaging and glass. In line with this approach, it has added many MNC giants to its customer base.

16 Feb 2020

SHARE MARKET-ONE MICROCAP MULTIBAGGER SHARE FOR INVESTMENT-



CUPID LTD
Chairman's Message
Dear Shareholders,
I would like to take this opportunity to thank you for your continuous support and for reposing your faith in the Company. It gives me immense pleasure to take you through the key developments and financial performance for the fiscal year 2019.
On the financial front, we ended the year with a Total Operating Income of ₹ 854.7 million (mn) for FY19 as compared to ₹ 806.0 mn in the corresponding period of the previous year reflecting an increase of 6.0 %. EBITDA stood at ₹230.4 mn as compared to ₹283.3 mn during the corresponding period of previous year resulting in decline in margin by 27.0%. Net profit was thereby impacted, and we closed the year with a net profit of ₹152.1 mn for FY19 as compared to ₹170.9 mn in the corresponding period of the previous year which is a decrease of 11.0 %.